SE415182B - Sett att framstella platinakoordinationsforeningar - Google Patents

Sett att framstella platinakoordinationsforeningar

Info

Publication number
SE415182B
SE415182B SE7308050A SE7308050A SE415182B SE 415182 B SE415182 B SE 415182B SE 7308050 A SE7308050 A SE 7308050A SE 7308050 A SE7308050 A SE 7308050A SE 415182 B SE415182 B SE 415182B
Authority
SE
Sweden
Prior art keywords
platino
associations
coordination
make
platino coordination
Prior art date
Application number
SE7308050A
Other languages
English (en)
Swedish (sv)
Inventor
M J Cleare
J D Hoeschele
B Rosenberg
Camp L L Van
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22991508&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE415182(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp filed Critical Research Corp
Publication of SE415182B publication Critical patent/SE415182B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7308050A 1972-06-08 1973-06-07 Sett att framstella platinakoordinationsforeningar SE415182B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26098972A 1972-06-08 1972-06-08

Publications (1)

Publication Number Publication Date
SE415182B true SE415182B (sv) 1980-09-15

Family

ID=22991508

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7308050A SE415182B (sv) 1972-06-08 1973-06-07 Sett att framstella platinakoordinationsforeningar
SE7810577A SE7810577L (sv) 1972-06-08 1978-10-10 Sett att framstella platinakoordinationsforeningar och anvendning derav inom cancerkemoterapin

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7810577A SE7810577L (sv) 1972-06-08 1978-10-10 Sett att framstella platinakoordinationsforeningar och anvendning derav inom cancerkemoterapin

Country Status (9)

Country Link
US (1) US4140707A (en, 2012)
JP (1) JPS5629676B2 (en, 2012)
CA (1) CA1023759A (en, 2012)
CH (2) CH588505A5 (en, 2012)
DE (1) DE2329485C3 (en, 2012)
FR (1) FR2187345B1 (en, 2012)
GB (1) GB1380228A (en, 2012)
NL (2) NL183724C (en, 2012)
SE (2) SE415182B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153540B (da) * 1978-07-06 1988-07-25 Tno Analogifremgangsmaade til fremstilling af platin-diamin-komplekser

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258051A (en) * 1975-01-10 1981-03-24 Research Corporation Method of treating viral infections
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4440782A (en) * 1977-03-01 1984-04-03 Research Corporation Method of treating viral infections
US4225529A (en) * 1977-10-19 1980-09-30 Johnson, Matthey & Co., Limited Compositions containing platinum
US4203912A (en) * 1977-10-19 1980-05-20 Johnson, Matthey & Co., Limited Compositions containing platinum
US4230631A (en) * 1977-10-19 1980-10-28 Johnson, Matthey & Co., Limited Platinum coordination compounds
SE7903359L (sv) * 1978-04-20 1979-10-21 Johnson Matthey Co Ltd Kompositioner innehallande platina
GB2019405A (en) * 1978-04-20 1979-10-31 Johnson Matthey & Co Ltd Pt Pt (II) and (IV) Amino-Acid Complexes
SE7903361L (sv) * 1978-04-20 1979-10-21 Johnson Matthey Co Ltd Kompositioner innehallande platina
JPS6034958B2 (ja) * 1978-09-02 1985-08-12 喜徳 喜谷 新規白金錯体
US4234500A (en) * 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
US4291027A (en) * 1979-03-07 1981-09-22 Engelhard Minerals & Chemicals Corp. Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
US4462998A (en) * 1979-06-20 1984-07-31 Engelhard Corporation Method of using a cis-platinum(II) amine ascorbate
US4505928A (en) * 1979-06-20 1985-03-19 Engelhard Corporation Pharmaceutical composition containing cis-platinum (II) amine lactate and a method of using same
US4271085A (en) * 1979-06-20 1981-06-02 Engelhard Minerals & Chemicals Corporation Cis-platinum (II) amine lactate complexes
US4457926A (en) * 1979-06-20 1984-07-03 Engelhard Corporation Cis-Platinum(II) amine ascorbate complexes
US4284579A (en) * 1979-07-17 1981-08-18 The United States Of America As Represented By The Of The Department Of Health & Human Services (N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
US4329299A (en) * 1979-08-23 1982-05-11 Johnson, Matthey & Co., Limited Composition of matter containing platinum
NL181434C (nl) * 1980-01-03 1987-08-17 Tno Platina(iv)-diamine-complexen, alsmede hun bereiding en toepassing.
GR75598B (en, 2012) * 1980-04-29 1984-08-01 Sanofi Sa
JPS56154493A (en) * 1980-04-30 1981-11-30 Shionogi & Co Ltd Novel platinum complex
US4322362A (en) * 1980-07-28 1982-03-30 Bristol-Myers Company Salts of 2-hydroxymalonate platinum complexes
AU538863B2 (en) * 1980-05-27 1984-08-30 Bristol-Myers Company Platinum complex salts have anti-tumor property
US4428943A (en) 1980-06-09 1984-01-31 The United States Of America As Represented By The Department Of Health And Human Services (N-Phosphonacetyl-L-aspartato) (1,2-diaminocyclohexane)platinum(II) or alkali metal salt
JPS5851959B2 (ja) * 1980-06-11 1983-11-19 呉羽化学工業株式会社 プラチナ化合物とその医薬組成物
JPS5716895A (en) * 1980-07-05 1982-01-28 Otsuka Chem Co Ltd Platinum 2 complex and antitumor agent containing the same as active principle
JPS57123198A (en) * 1981-01-23 1982-07-31 Shionogi & Co Ltd Novel platinum complex
JPS5896024A (ja) * 1981-10-16 1983-06-07 リチヤ−ド・エフ・ストツケル 白金毒解毒剤
US4500465A (en) * 1982-06-28 1985-02-19 Engelhard Corporation Solubilized platinum (II) complexes
US4584392A (en) * 1982-11-10 1986-04-22 Inco Alloys International, Inc. Platinum and palladium complexes
US4560782A (en) * 1982-11-19 1985-12-24 Research Corporation Anti-tumor diplatinum coordination compounds
IL67789A (en) * 1983-01-31 1986-09-30 Yissum Res Dev Co Amino-substituted malonato platinum(ii)complexes and method for their preparation
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
US4906646A (en) * 1983-03-31 1990-03-06 Board Of Governors Of Wayne State University Method and composition for the treatment of tumors by administering a platinum coordination compound and a calcium channel blocker compound of the dihydropyridine class
US4617189A (en) * 1983-04-14 1986-10-14 Stockel Richard F Use of selenium-containing compounds for negating the toxic effects of platinum compounds used in chemotherapy, and a novel selenium-containing platinum compound and use thereof as an anti-cancer medicine
JPS59222498A (ja) * 1983-06-01 1984-12-14 Shionogi & Co Ltd 新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤
US4758588A (en) * 1983-06-20 1988-07-19 Research Corporation Technologies Diaminocyclohexane platinum complexes
US4661516A (en) * 1983-06-20 1987-04-28 Research Corporation Diaminocyclohexane platinum complexes
EP0130482B1 (en) * 1983-06-20 1988-12-28 Research Corporation Diaminocyclohexane platinum complexes, process for preparing same and pharmaceutical compositions containing same
US4710577A (en) * 1983-08-05 1987-12-01 Yoshinori Kidani Cytostatic platinum organic complexes
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
CH665421A5 (de) * 1984-01-23 1988-05-13 Inst Obschei I Neoorganichesko Gemischte karboxylatokomplexe von platin (ii) und verfahren zu ihrer herstellung.
US4843161A (en) * 1984-06-01 1989-06-27 Massachusetts Institute Of Technology Platinum-intercalative complexes for the treatment of cancer
GB8416048D0 (en) * 1984-06-22 1984-07-25 Johnson Matthey Plc Anti-tumour compounds of platinum
EP0169645A1 (en) * 1984-06-27 1986-01-29 Johnson Matthey Public Limited Company Platinum co-ordination compounds
US4645661A (en) * 1984-06-29 1987-02-24 St. Jude Children's Research Hospital Method for alleviating cisplatin-induced nephrotoxicity and dithiocarbamate compounds for effecting same
US4696918A (en) * 1984-11-02 1987-09-29 Johnson Matthey Public Limited Company Solubilized platinum compound
US4588831A (en) * 1984-11-09 1986-05-13 Natec Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
US4665210A (en) * 1984-12-17 1987-05-12 American Cyanamid Company Platinum complexes of aliphatic tricarboxylic acids
ZA86704B (en) * 1985-02-23 1986-10-29 Asta Werke Ag Chem Fab Tumor retarding(1-benzyl-ethylenediamine9-platin(ii)-complexes
CA1274529A (en) * 1985-09-05 1990-09-25 Federico Sampedro Platinum(ii) complexes of 1,1-cyclobutane- dicarboxylate and process for their production
US4658047A (en) * 1985-09-27 1987-04-14 The United States Of America As Represented By The Department Of Health And Human Services Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US4760157A (en) * 1986-01-31 1988-07-26 American Cyanamid Company (2,2,-bis(aminomethyl)-1,3-propanediol-N,N')platinum complexes
US4670458A (en) * 1986-01-31 1987-06-02 American Cyanamid Company Hydroxylated 1,2-diaminocyclohexane platinum complexes
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US6884418B1 (en) * 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
ES2160117T3 (es) * 1994-02-07 2001-11-01 Pliva Pharmaceutical Industry Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion.
JP3154399B2 (ja) * 1996-07-04 2001-04-09 デビオファーム エス．アー． 白金化合物の製造方法
US5922689A (en) * 1995-09-11 1999-07-13 Unitech Pharmaceuticals, Inc. Cisplatin analogs for cancer treatment
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
CN1068002C (zh) * 1997-04-30 2001-07-04 中国科学院大连化学物理研究所 铂抗癌药物及合成
PT1068870E (pt) * 1998-04-03 2006-10-31 Ajinomoto Kk Agentes antitumorais
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2001036431A1 (en) 1999-11-15 2001-05-25 Parker Hughes Institute Diamino platinum (ii) antitumor complexes
US6545010B2 (en) * 2000-03-17 2003-04-08 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
DK1313508T5 (da) * 2000-06-30 2017-03-20 Lilly Co Eli Kombination indeholdende et antifolat og methylmalonsyresænkende middel
DE10032256C2 (de) * 2000-07-03 2003-06-05 Infineon Technologies Ag Chip-ID-Register-Anordnung
TWI315982B (en) 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
JP2005508323A (ja) * 2001-09-26 2005-03-31 インターミューン インコーポレイテッド 癌治療のための医薬組成物及び方法
TWI272273B (en) * 2002-07-16 2007-02-01 Sonus Pharma Inc Platinum compounds
US7160908B2 (en) * 2003-03-04 2007-01-09 Unitech Pharmaceuticals, Inc. Dynamic anticancer platinum compounds
US7129368B2 (en) * 2004-03-15 2006-10-31 Sonus Pharmaceuticals, Inc. Platinum carboxylate anticancer compounds
BRPI0606480A (pt) 2005-01-21 2008-03-11 Astex Therapeutics Ltd compostos farmacêuticos
DE602005014393D1 (de) * 2005-03-28 2009-06-18 Dabur Pharma Ltd Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
CN101443002B (zh) 2006-05-09 2012-03-21 诺瓦提斯公司 包含铁螯合剂和抗肿瘤药的组合及其用途
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
HRP20120683T1 (hr) * 2006-10-27 2012-09-30 Genentech Protutijela i imunokonjugati te njihove uporabe
EP2219672B1 (en) 2007-11-09 2016-02-17 Peregrine Pharmaceuticals, Inc. Anti-vegf antibody compositions and methods
DK2644204T3 (en) 2008-03-18 2017-07-03 Genentech Inc Combinations of an anti-HER2 antibody-drug conjugate and pertuzumab
RU2482855C2 (ru) 2008-03-27 2013-05-27 Тайхо Фармасьютикал Ко., Лтд. Противоопухолевое средство, включающее производное цитидина и карбоплатин
JP4664424B2 (ja) * 2008-09-03 2011-04-06 ユニーテック株式会社 白金錯体及びそれを含む医薬組成物
US8598188B2 (en) 2009-03-12 2013-12-03 Kinki University Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer
WO2012135781A1 (en) 2011-04-01 2012-10-04 Genentech, Inc. Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
EP2508525A1 (en) 2011-04-05 2012-10-10 Bayer Pharma Aktiengesellschaft Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
JP5179628B2 (ja) 2011-07-15 2013-04-10 ユニーテック株式会社 ４価白金錯体及びそれを含む医薬組成物
CN109939236A (zh) 2012-06-08 2019-06-28 豪夫迈·罗氏有限公司 用于治疗癌症的磷酸肌醇3激酶抑制剂化合物和化疗剂的突变选择性及组合
RS62412B1 (sr) 2015-12-09 2021-10-29 Univ Wien Med Jedinjenja platine funkcionalizovana sa monomaleimidom za terapiju raka
WO2017192290A1 (en) 2016-05-04 2017-11-09 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs
CN107773556B (zh) * 2016-08-26 2020-08-18 广州安好医药科技有限公司 一种具有抗肿瘤药物功效的联合用药物
BR112019018767A2 (pt) 2017-04-03 2020-05-05 Hoffmann La Roche anticorpos, molécula de ligação ao antígeno biespecífica, um ou mais polinucleotídeos isolados, um ou mais vetores, célula hospedeira, método para produzir um anticorpo, composição farmacêutica, usos, método para tratar uma doença em um indivíduo e invenção

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153540B (da) * 1978-07-06 1988-07-25 Tno Analogifremgangsmaade til fremstilling af platin-diamin-komplekser

Also Published As

Publication number Publication date
DE2329485C3 (de) 1980-07-31
US4140707A (en) 1979-02-20
US4140707B1 (en, 2012) 1989-12-19
CH605550A5 (en, 2012) 1978-09-29
NL183724C (nl) 1989-01-02
FR2187345B1 (en, 2012) 1976-12-31
JPS4948621A (en, 2012) 1974-05-11
CH588505A5 (en, 2012) 1977-06-15
NL183724B (nl) 1988-08-01
FR2187345A1 (en, 2012) 1974-01-18
NL930049I2 (nl) 1993-11-16
NL930049I1 (nl) 1993-09-01
GB1380228A (en) 1975-01-08
SE7810577L (sv) 1978-10-10
JPS5629676B2 (en, 2012) 1981-07-09
NL7307863A (en, 2012) 1973-12-11
DE2329485B2 (de) 1979-11-22
DE2329485A1 (de) 1973-12-20
CA1023759A (en) 1978-01-03

Similar Documents

Publication Publication Date Title
SE415182B (sv) Sett att framstella platinakoordinationsforeningar
SE406554B (sv) Sett att framstella mikropartiklar
SE396070B (sv) Sett att framstella metylsubstituerade kinoner
SE417089B (sv) Sett att framstella en sulfonamidoarylforening
SE412586B (sv) Sett att framstella isoflavonderivat
SE417982B (sv) Sett att framstella cefalosporinforeningar
SE421690B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE8205332D0 (sv) Sett att framstella hoghallfast stalband
SE7608643L (sv) Sett att framstella segmentpolymerisat
SE382215B (sv) Sett att framstella kromanderivat
SE391181B (sv) Sett att framstella kinazolinderivat
SE399255B (sv) Sett att framstella kinazolinonderivat
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE7603276L (sv) Sett att framstella prostansyraderivat
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE381651B (sv) Sett att framstella karbamater
SE420087B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE405966B (sv) Sett att framstella peptider
SE400078B (sv) Sett att framstella kinazolinonderivat
SE397679B (sv) Sett att framstella kinazolinonderivat
SE381831B (sv) Sett att tillverka kylare
SE400281B (sv) Sett att framstella kinazolinonderivat
SE399712B (sv) Sett att framstella pregnansyraderivat
SE389443B (sv) Sett att framstella en fergad fodoemneskomposition

Legal Events

Date Code Title Description
SPCG Supplementary protection certificate granted

Free format text: 7308050, EXPIRES: 19990523